Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NECITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NECITUMUMAB: Safety Overview

Metric NARATRIPTAN NECITUMUMAB
Total FAERS Reports 526 367
Deaths Reported 9 69
Death Rate 1.7% 18.8%
Hospitalizations 102 131
Average Patient Age 49.2 yrs 65.4 yrs
% Female Patients 90.0% 20.0%
FDA Approval Date Apr 22, 2011 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription